Affordable Access

A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.

Authors
  • Shiuey, Y
  • Ambati, B K
  • Adamis, A P
Type
Published Article
Journal
Ophthalmology
Publisher
Elsevier
Publication Date
Aug 01, 2000
Volume
107
Issue
8
Pages
1512–1517
Identifiers
PMID: 10919900
Source
Medline
License
Unknown

Abstract

Topical ketorolac 0.5% used four times daily is no better than artificial tears at relieving the symptoms or signs of viral conjunctivitis and produces more stinging than artificial tears.

Report this publication

Statistics

Seen <100 times